Old Web
English
Sign In
Acemap
>
authorDetail
>
John S Manavalan
John S Manavalan
University of Virginia
Cancer research
Chemistry
kinase inhibition
IRAK4
Mutant
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tolinapant (ASTX660), a Non-Peptidomimetic Antagonist of cIAP1/2 and XIAP, and the HDAC Inhibitor Romidepsin Are Synergistic in in Vitro Models of T Cell Lymphoma
2021
Blood
John S Manavalan
Ipsita Pal
Aidan Pursley
George Ward
Tomoko Smyth
Martin Sims
David J. Feith
Thomas P. Loughran
Owen A OConnor
Enrica Marchi
Show All
Source
Cite
Save
Citations (0)
Targeting MYD88-Mutant DLBCL with IRAKIMiDs: A Comparison to IRAK4 Kinase Inhibition and Evaluation of Synergy with Rational Combinations
2020
Blood
Jennifer K. Lue
John S Manavalan
Christine Klaus
Rahul Kanik
Andre M. Grilo
Alice McDonald
Jared A. Gollob
Duncan Walker
Owen A OConnor
Nello Mainolfi
Show All
Source
Cite
Save
Citations (0)
1